Mahkam Zanganeh
Co-Chief Executive Officer at Summit Therapeutics · 8 reported transactions in 1 company · latest trade Jun 12, 2026
Their record
Across their whole record, 1 purchase can be measured; 0 did better than the S&P 500 over the next 6 months.
Typical move −12.6%, S&P 500 +5.0% over the same days.
Their trades
Bought | Jun 12, 2026 | Jun 12, 2026 close $14.01 → Oct 28, 2026 close $15.77. S&P 500 +3.8% over the same days. | ||
Bought | Jun 4, 2026 | Jun 4, 2026 close $14.84 → Oct 28, 2026 close $15.77. S&P 500 +1.7% over the same days. | ||
Bought | Oct 21, 2025 | Oct 21, 2025 close $18.74 → Oct 28, 2026 close $15.77. S&P 500 +14.7% over the same days. | ||
Bought | Sep 11, 2025 | Sep 11, 2025 close $18.60 → Oct 28, 2026 close $15.77. S&P 500 +17.0% over the same days. | ||
Bought | Sep 10, 2025 | Sep 10, 2025 close $17.60 → Oct 28, 2026 close $15.77. S&P 500 +18.0% over the same days. |
BoughtSummit Therapeutics
$49.99M
Jun 12, 2026 close $14.01 → Oct 28, 2026 close $15.77. S&P 500 +3.8% over the same days.
BoughtSummit Therapeutics
$1.46M
Jun 4, 2026 close $14.84 → Oct 28, 2026 close $15.77. S&P 500 +1.7% over the same days.
BoughtSummit Therapeutics
$500K
Oct 21, 2025 close $18.74 → Oct 28, 2026 close $15.77. S&P 500 +14.7% over the same days.
BoughtSummit Therapeutics
$90.3K
Sep 11, 2025 close $18.60 → Oct 28, 2026 close $15.77. S&P 500 +17.0% over the same days.
BoughtSummit Therapeutics
$5.89M
Sep 10, 2025 close $17.60 → Oct 28, 2026 close $15.77. S&P 500 +18.0% over the same days.